TickerFactsScreenerDevelopers

Akari Therapeutics Plc (AKTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$792.0K2011: -$2.25M2012: -$3.67M2013: -$3.61M2014: -$1.92M2015: -$30.58M2016: -$27.25M2017: -$37.78M2018: -$20.79M2019: -$16.96M2020: -$17.98M2021: -$17.21M2022: -$23.09M2023: -$16.81M2024: -$21.64M2025: -$17.27M-$17.27M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$17.27M+20.2%
2024-$21.64M-28.8%
2023-$16.81M+27.2%
2022-$23.09M-34.1%
2021-$17.21M+4.3%
2020-$17.98M-6.0%
2019-$16.96M+18.4%
2018-$20.79M+45.0%
2017-$37.78M-38.7%
2016-$27.25M+10.9%
2015-$30.58M-1493.5%
2014-$1.92M+46.8%
2013-$3.61M+1.7%
2012-$3.67M-63.2%
2011-$2.25M-183.7%
2010-$792.0K—